|
|
||||||||
CRC Experimental Haematology Group, Paterson Institute for Cancer Research, Manchester, United Kingdom
Key Words. CD34 • Cord Blood • Ex vivo expansion • Cell cycle • Serum-free • G0
Yvonne J. Summers, CRC Experimental Haematology Group, Paterson Institute for Cancer Research, Manchester, Mzo 4Bx, United Kingdom. Telephone: 0161-466-3239; Fax: 0161-466-3033; e-mail: ysummers{at}picr.man.ac.uk
We examined the functional differences between G0 and G1 cord blood CD34+ cells for up to 24 weeks in serum-free suspension culture, containing Flt-3 ligand, thrombopoietin and stem cell factor. By week 24, there is more than a 1,000-fold difference in granulocyte, macrophage-colony-forming cells (GM-CFC) cumulative production between the two populations, with cultures initiated from G0 demonstrating an amplification of 1.1 x 105-1.8 x 106 of GM-CFC compared to 45-2.7 x 103 for the G1 cells. Cells from the initial G0 population are able to produce about 250-fold higher numbers of BFU-E than those from G1 which translates to 3 x 103-1.1 x 105-fold expansion and 25-390-fold expansion for G0 and G1, respectively. This amplification of the progenitor cells is reflected in finding that a greater proportion of the progeny of the G0 population are CD34+, resulting in a 600-fold expansion of CD34+ cells at week 8. As in other in vitro systems, total cell expansion is less discriminatory of stem cell behavior than progenitor cells, and there is no significant difference in total cell numbers between G0 and G1 cultures with a mean fold expansion of 2 x 107 at 24 weeks.
This article has been cited by other articles:
![]() |
T. U. Bracker, B. Giebel, J. Spanholtz, U. R. Sorg, L. Klein-Hitpass, T. Moritz, and J. Thomale Stringent Regulation of DNA Repair During Human Hematopoietic Differentiation: A Gene Expression and Functional Analysis Stem Cells, March 1, 2006; 24(3): 722 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Hermitte, P. Brunet de la Grange, F. Belloc, V. Praloran, and Z. Ivanovic Very Low O2 Concentration (0.1%) Favors G0 Return of Dividing CD34+ Cells Stem Cells, January 1, 2006; 24(1): 65 - 73. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. J. Summers, C. M. Heyworth, E. A. de Wynter, C. A. Hart, J. Chang, and N. G. Testa AC133+ G0 Cells from Cord Blood Show a High Incidence of Long-Term Culture-Initiating Cells and a Capacity for More Than 100 Million-Fold Amplification of Colony-Forming Cells In Vitro Stem Cells, September 1, 2004; 22(5): 704 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Quesenberry, G. A. Colvin, and J.-F. Lambert The chiaroscuro stem cell: a unified stem cell theory Blood, December 15, 2002; 100(13): 4266 - 4271. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. Lu, C. Quan, F. Li, L. Vida, and G. R. Honig Hematopoietic Progenitor Cells Derived from Embryonic Stem Cells: Analysis of Gene Expression Stem Cells, September 1, 2002; 20(5): 428 - 437. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
